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Synthetic Glycoprotein Mimics
Inhibit L-Selectin-Mediated Rolling
and Promote L-Selectin Shedding
extravasation of cells [18–23]. Thus, compounds that
inhibit L-selectin-mediated rolling may function as leads
for the development of anti-inflammatory agents [1, 2,
15, 24].
One approach to modulating L-selectin-mediated roll-
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1101 University Avenue L-selectin have been identified, including the highly gly-
cosylated mucins GlyCAM-1, PNAd, CD34, PSGL-1, andUniversity of Wisconsin-Madison
Madison, Wisconsin 53706 podocalyxin [17, 25–31]. In addition, a glycolipid sul-
fatide also interacts with L-selectin [32]. Of these li-3 Department of Immunology
Wolfson Building gands, GlyCAM-1 is one of the best characterized. Gly-
CAM-1 is a highly O-glycosylated protein that presentsWeizmann Institute of Science
76100 Rehovot saccharide chains containing sulfated derivatives of the
tetrasaccharide sialyl Lewis x (sLex) [33]. The sulfationIsrael
of carbohydrate determinants on GlyCAM-1 strengthens
L-selectin binding [34] and a key sulfation site has been
found to be the 6-position of glucosamine [24, 35]. TheSummary
binding of L-selectin to GlyCAM-1 also may be en-
hanced by the presentation of multiple carbohydrateL-selectin is a leukocyte cell-surface protein that facil-
epitopes, as GlyCAM-1 is a mucin-like protein [26]. We,itates the rolling of leukocytes along the endothelium,
along with others, have found that synthetic carbohy-a process that leads to leukocyte migration to a site
drate derivatives sulfated at the 6-position exhibit en-of infection. Preventing L-selectin-mediated rolling
hancements of 2- to 5-fold in L-selectin inhibitory activityminimizes leukocyte adhesion and extravasation;
over the corresponding unsulfated forms [1, 24, 35–42],therefore, compounds that inhibit rolling may act as
and that multivalent synthetic compounds have greateranti-inflammatory agents. To investigate the potential
avidity for L-selectin than their monovalent counterpartsrole of multivalent ligands as rolling inhibitors, com-
[1, 40, 43–47].pounds termed neoglycopolymers were synthesized
We previously assessed the inhibition of L-selectin-that possess key structural features of physiological
mediated rolling by compounds designed to mimic theL-selectin ligands. Sulfated neoglycopolymers substi-
natural glycoprotein ligands that bind L-selectin [46]. Wetuted with sialyl Lewis x derivatives (3,6-disulfo Lewis
tested isomeric monovalent and multivalent derivativesx or 6-sulfo sialyl Lewis x) or a sulfatide analog (3,6-
displaying either the 36-disulfo Lex epitope (1) or thedisulfo galactose) inhibited L-selectin-mediated roll-
3,6-disulfo Lex epitope (2) (Figure 1A). Only compounding of lymphoid cells. Functional analysis of the inhibi-
1 inhibited rolling. The inhibition by 1 could result fromtory ligands indicates that they also induce proteolytic
blocking L-selectin interactions necessary for rolling,release of L-selectin. Thus, their inhibitory potency
promoting the proteolytic cleavage (or shedding) of themay arise from their ability to induce shedding. Our
extracellular portion of L-selectin, or both.data indicate that screening for compounds that pro-
A method for inhibiting L-selectin activity is to inducemote L-selectin release can identify ligands that inhibit
its shedding, or proteolytic cleavage, from the cell sur-rolling.
face. The shedding of L-selectin appears to occur in
physiological settings [48, 49]. For example, during an
Introduction inflammatory response, the proteolytic cleavage of
L-selectin can suppress leukocyte accumulation [49].
The inflammatory response involves the recruitment of In vitro L-selectin shedding can be elicited by a number
leukocytes to a site of injury or infection [1–8]. During this of agents [50–56]. Synthetic multivalent ligand 36-dis-
process, leukocytes roll along the endothelium, adhere ulfo Lex-substituted 1 was found to induce downregula-
tightly to the endothelium wall, and finally migrate into tion of L-selectin [57] along with inhibition of L-selectin-
the inflamed tissue. In certain disease states, aggressive mediated rolling [46], suggesting a relationship between
leukocyte migration is detrimental [2, 9–13]. Thus, com- the two processes. The generality of this relationship,
pounds that inhibit the steps in the inflammatory re- however, was unknown. We therefore compared the
sponse have been sought [1, 2, 4, 11, 14, 15]. Given activities of a series of multivalent ligands in assays that
the sequential nature of leukocyte migration, the initial assess each activity.
rolling step is a promising target for blocking the inflam-
matory process. One mediator of rolling is the leukocyte Results
cell-surface protein, L-selectin, that interacts with endo-
thelial ligands [10, 16, 17]. Eliminating L-selectin-medi- Neoglycopolymers Inhibit L-Selectin-
ated rolling has been shown to impair the subsequent Mediated Rolling
To identify inhibitors of L-selectin-mediated rolling, we
examined the activities of neoglycopolymers displaying*Correspondence: kiessling@chem.wisc.edu
Chemistry & Biology
726
Table 1. Inhibition of L-Selectin-Mediated Cell Rolling (PNAd)
Compound IC50
3,6-disulfo Lex neoglycopolymer 1 0.002 M
sLex neoglycopolymer 3 60.0 M
6-sulfo sLex neoglycopolymer 4 0.022 M
Mouse pre-B cell line 300.19 transfected with human L-selectin was
treated with compounds, and the mixture was perfused through a
laminar flow chamber coated with PNAd. IC50 values are reported
on a saccharide residue basis.
pound 1 contains a sulfate group at the 3-position of
galactose however, whereas compound 4 possesses
the sialic acid moiety found in natural glycoproteins.
Thus, the role of the sialic acid residue could be as-
sessed. Additionally we wanted to examine whether 3,6-
disulfo galactose-substituted neoglycopolymer 5 (Fig-
ure 1C) is able to block rolling, as this compound had
been shown to inhibit L-selectin binding in static binding
assays [32, 59].
Neoglycopolymers substituted with 36-disulfo Lex,
sLex, and 6-sulfo sLex derivatives (1, 3, and 4; Figure 1)
were tested in a rolling assay. In this assay, the rolling
of L-selectin transfected pre-B cells on a surface bearing
the peripheral node addressin (PNAd) was assessed
[60–62]. PNAd, a mixture of sialylglycoproteins, is a li-
gand for L-selectin that supports lymphocyte rolling [25,
63]. Surprisingly, neoglycopolymers bearing unsulfated
sLex (3) residues did not inhibit rolling even at a saccha-
ride residue concentration of 60 M (Table 1). In con-
trast, the related compound, 6-sulfo sLex-substituted
neoglycopolymer 4 is an inhibitor (IC50  0.022 M). This
result indicates that sulfation is a key modification for
inhibitors of rolling. When examining the importance
of the sialyl group, neoglycopolymers substituted with
derivatives 6-sulfo sLex (4) and 3,6-disulfo Lex (1) were
both capable of inhibiting L-selectin-mediated rolling
Figure 1. Synthetic Compounds Generated Putative as L-Selectin (Table 1). The activity of 1 is consistent with previous
Ligands studies demonstrating that it inhibits L-selectin-medi-
(A) Synthetic multivalent Lex-derived ligands designed to bind ated cell rolling on GlyCAM-1 [46], another L-selectin
L-selectin. ligand. Lymphocytes exhibit tethering and rolling prop-
(B) Synthetic multivalent sLex-derived ligands designed to bind
erties on both substrates but their interactions withL-selectin.
GlyCAM-1 tend to be of higher functional affinity [62].(C) Synthetic multivalent derivative designed to mimic features of
Furthermore, the density of GlyCAM-1 was higher thansulfatide.
the density of PNAd, a property that affects interactions,
as observed when lower densities of GlyCAM-1 resulted
in reduced interactions with compound 1 (data notdifferent saccharide epitopes. We compared unsulfated
(3) and sulfated (4) multivalent derivatives of sLex in a shown). Unsialylated 1 was 10-fold more effective than
sialylated multivalent ligand 4, indicating that sulfationlymphocyte rolling assay (Figure 1B). Sulfated deriva-
tives of sLex have been shown to exhibit greater L-selec- at the 3-position is more effective than the sialylation
in these multivalent ligands. Thus, compound 1 is one oftin binding activity [1, 17, 24, 35–39, 41, 42]; however,
their activities as inhibitors of rolling had not been exam- the most potent inhibitors of L-selectin-mediated rolling
known.ined. Because we had previously observed rolling inhibi-
tion with a neoglycopolymer displaying epitopes lacking Glycolipid sulfatides are also L-selectin ligands [32].
Presumably, the collection of sulfated glycolipids as-the sialic acid residue [46], we wished to address the
importance of this moiety in the context of a multivalent sembles into a noncovalent multivalent array that inter-
acts with L-selectin. To explore multivalent ligands basedpresentation. We therefore compared multivalent sialy-
lated (4) and unsialylated (1) derivatives of Lex in a rolling on sulfatide, we prepared 3,6-disulfo galactose-substi-
tuted neoglycopolymer 5 (Figure 1C) [59] and tested itsassay (Figure 1). Both compounds display saccharides
that are sulfated at the 6-position of glucose, and both effectiveness at inhibiting rolling of L-selectin-trans-
fected pre-B cells on immobilized GlyCAM-1. As withpossess an anionic charge at the 3-position, which has
been implicated in L-selectin binding [36, 58]. Com- 36-disulfo Lex–substituted 1, neoglycopolymer 5 effec-
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Table 2. Neoglycopolymer Inhibition of L-Selectin Rolling
Compound IC50
3,6-disulfo Lex neoglycopolymer 1 15 M
3,6-disulfo Lex neoglycopolymer 2 5000 M
3,6-disulfo galactose neoglycopolymer 5 121 M
Mouse pre-B cell line 300.19 transfected with human L-selectin was
preincubated with compounds and perfused through a laminar flow
chamber coated with GlyCAM-1. Inhibitory concentrations are re-
ported on a per saccharide basis.
tively blocked L-selectin-mediated rolling on GlyCAM-1
(Table 2). Neoglycopolymer 5 was found to be approxi-
mately 10-fold less effective at inhibiting L-selectin-
mediated rolling than was 1. This result suggests that
a multivalent array of the more complex trisaccharide
derivative has higher functional affinity for L-selectin
than does monosaccharide-substituted 5. This finding Figure 2. Ligand-Induced Shedding of L-Selectin
is consistent with others indicating that interactions be- Neoglycopolymers substituted with 3,6-disulfo Lex 1, 6-sulfo sLex
yond Coulombic forces contribute to the binding of sul- 4, and 3,6-disulfo galactose 5 epitopes promote L-selectin shed-
ding. The neoglycopolymers substituted with 3,6-disulfo Lex 2 andfated glycoproteins to L-selectin [47].
sLex 3 epitopes do not. Human lymphocytes were incubated with
267 M (4 mM on a per saccharide basis) neoglycopolymer or 10–20
ng/mL PMA for 30 min at 37C. L-selectin levels were detected withNeoglycopolymer Induction of L-Selectin
FITC-conjugated anti-L-selectin antibody as measured on a flowDownregulation
cytometer. The symbols * and ** represent statistical significanceOne mechanism by which the neoglycopolymers could
to t  0.0005 and t  0.005, respectively, as measured by t test.
inhibit L-selectin-mediated rolling is by binding to it
thereby blocking contacts required for rolling. Alterna-
tively, these compounds could promote the shedding L-Selectin Downregulation by Multivalent Ligands
of L-selectin, a process that would also inhibit rolling. Occurs through Shedding
We previously found that 3,6-disulfo Lex–substituted Flow cytometry data indicate that the treatment of
neoglycopolymer 1 inhibits L-selectin-mediated rolling lymphocytes with active neoglycopolymers results in
[46] and induces L-selectin downregulation [57]. These L-selectin downregulation (Figure 2). We suspected that
results suggest that this compound may ameliorate roll- this ligand activity results from L-selectin shedding, as
ing by promoting the proteolytic cleavage of L-selectin. proteolytic cleavage of the extracellular domain has
The ability of neoglycopolymers to induce shedding, been reported [50]. To test whether the neoglycopoly-
however, was tested using human neutrophils whereas mers induce shedding, the supernatant from neoglyco-
rolling activity was tested in an assay using lymphoid- polymer-treated lymphoid human Jurkat cells was ana-
derived cell lines. To examine the generality of this re- lyzed for the presence of soluble L-selectin by Western
sult, we tested a series of neoglycopolymers for their blot. L-selectin on this cell line is known to undergo
abilities to induce L-selectin shedding from lymphoid proteolytic cleavage [56, 66], and neoglycopolymers are
cells. capable of inducing L-selectin downregulation on Jurkat
To test for L-selectin downregulation, lymphocytes cells as well as lymphocytes (Figure 3A). When cells
were treated with a compound of interest, and their were treated with a neoglycopolymer substituted with
L-selectin levels were assessed by flow cytometry [64]. 36-disulfo Lex (1), an increase in soluble L-selectin over
The flow cytometry measurements were conducted us- basal levels was detected (Figures 3B–3C). This result
ing the anti-L-selectin antibody DREG-56. We had indicates that neoglycopolymers promote downregula-
shown previously that the neoglycopolymers do not tion of L-selectin via shedding.
block DREG-56 binding to cells displaying L-selectin
[65]. All of the multivalent ligands capable of inhibiting
rolling induced L-selectin downregulation (Figure 2). Discussion
These include neoglycopolymers substituted with 36-
disulfo Lex (1), 6-sulfo sLex (4), and 3,6-disulfo galactose Structural Parameters of Inhibition
of L-Selectin-Mediated Rollingderivatives (5). Conversely, the ligands with no activity
in the rolling assay did not elicit this response. These A number of assays have been employed to identify
inhibitors of the selectins [1, 12, 24]. Our previous stud-compounds include neoglycopolymers substituted with
3,6-disulfo Lex (2) and sLex (3) epitopes. These results ies indicate that inhibitors identified in static assays
may not always function in rolling assays [46]. Thus, weindicate that the ligand features important in com-
pounds that promote L-selectin downregulation are compared different multivalent ligands in the L-selectin-
mediated rolling assay. Unexpectedly, we found thatthose found in inhibitors of rolling. This relationship sug-
gests that the neoglycopolymers block rolling through sialylated but unsulfated sLex-substituted neoglyco-
polymer 3 was incapable of inhibiting rolling. Multivalentdownregulation of L-selectin.
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sLex derivatives have been found to inhibit L-selectin
[43–45] and sLex supports cell-free rolling on L-selectin
[67]. However, the efficacy of a multivalent ligand dis-
playing sLex epitopes in blocking the rolling of L-selec-
tin-displaying cells had not been tested. Interestingly,
unsulfated glycoprotein mucins are not effective ligands
for L-selectin [34, 68]. Our data indicate that 6-sulfation
of the sLex epitope makes a critical contribution to activ-
ity of the multivalent ligands. This result is consistent
with the importance of 6-sulfation for L-selectin binding
to natural glycoprotein ligands [69–71].
Sulfation is an important parameter for neoglycopoly-
mer-inhibition of L-selectin rolling, but the sulfated li-
gands tested vary in potency. The neoglycopolymer
substituted with the trisaccharide sLex mimic, 36-
disulfo Lex-substituted neoglycopolymer 1, was 10-fold
more potent than the tetrasaccharide 6-sulfo sLex-sub-
stituted neoglycopolymer 4 in the rolling assay. This
result is somewhat surprising as the replacement of a
sulfo group with a sialic acid residue might be expected
to afford a ligand with increased activity. However, our
results are consistent with others that suggest that
L-selectin ligands may interact with an extended binding
site [32, 47, 72, 73]. This purported binding is similar to
the interaction of related selectin, P-selectin, with its
ligand, PSGL-1 [58]. Consequently, by retaining the an-
ionic charge but not the bulky sialyl group, 36-disulfo
sLex-substituted neoglycopolymer 1 may more effec-
tively occupy this secondary site and therefore engage
in a more productive interaction with L-selectin than
neoglycopolymer 4.
Information about the importance of sulfate group
placement is also obtained from the activity of 3,6-
disulfo galactose-substituted neoglycopolymer 5. This
compound possesses a sulfate group at the 6-position
of galactose. Although compound 5 effectively inhibits
rolling, the trisaccharide-substituted compound simi-
larly sulfated at the 6-position of galactose (36-disulfo
sLex-substituted neoglycopolymer 2) did not. These
data indicate that the spacing of the sulfate groups
within the multivalent display, and not just on the carbo-
hydrate epitope, is critical. These results provide further
support that L-selectin has a binding site that interacts
with polyanionic moieties that extends beyond that for
Figure 3. Inhibition of Neoglycopolymer-Induced L-Selectin Pro- sLex and its derivatives [32, 47, 72, 73]. Our data indicate
ceeds via Shedding
that this secondary binding site has specific structural
(A) Neoglycopolymer substituted with 3,6-disulfo Lex (1) promotes requirementsnot all polyanionic compounds can ef-
L-selectin shedding on Jurkat cells in a manner similar to that ob-
fectively occupy it. Consistent with this model, the sim-served using human lymphocytes. Cells were incubated with 267
ple sulfated ligand 5 was found to be approximatelyM 1 for 30 min at 37C and L-selectin levels were detected with
FITC-conjugated anti-L-selectin antibody as measured on a flow 10-fold less effective than 36-disulfo sLex-substituted
cytometer. Neoglycopolymer concentrations are calculated on a per neoglycopolymer 1.
neoglycopolymer basis. Neoglycopolymer 5 substituted with 3,6-disulfo galac-
(B) To detect if neoglycopolymers induce soluble L-selectin, Jurkat tose residues has been found to bind multiple copies
cells were untreated or treated with 134 M 1 or 100 ng/mL phorbol
of L-selectin on the cell surface [65, 74]. Furthermore,myristate acetate (PMA) for 30 min at 37C. PMA is known to induce
neoglycopolymers, but not monomers, have been pre-L-selectin shedding from cells. Supernatant was collected and a
Western blot was performed. The soluble L-selectin bands reflect viously shown to inhibit rolling [46]. Therefore, sulfation
the percentage of L-selectin removed as determined by flow cy- patterns presumably not only affect epitope recognition
tometry.
(C) To confirm specificity of antibodies (Ab) in the Western blot,
controls were performed with PMA-induced soluble L-selectin (sL-
chased L-selectin and then used in the Western blot. To confirmthatselectin) or purchased L-selectin. To show binding with primary
antibody, samples were probed with sheep anti-human L-selectin the secondary antibody did not bind nonspecifically, samples were
probed with sheep anti-human IgG. All lanes were visualized after(L-sel) antibody. To confirm specificity of the primary antibody,
sheep anti-L-selectin human antibody was pre-cleared with pur- treatment with peroxidase-conjugated donkey anti-sheep antibody.
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but, within the context of a multivalent ligand, allow for induce L-selectin release. Therefore, the flow cytometry-
based assay results mirror the rolling inhibition results,clustering of L-selectin and inhibition of rolling.
but ELISA data do not.
Our results suggest that the flow cytometry assay for
Relationship between Inhibition of L-Selectin-
L-selectin shedding provides an effective method for
Mediated Rolling and L-Selectin Shedding
determining multivalent ligands that function as inhibi-
The shedding of L-selectin may serve as an important tors of L-selectin-mediated rolling. The shedding assay
mechanism by which the rolling process could be con- identifies compounds that may act by both blocking the
trolled [75, 76]. L-selectin shedding may be elicited by L-selectin binding site and promoting L-selectin down-
clustering of the protein [77], as suggested by studies regulation. By inducing the removal of L-selectin, the
with nonspecific chemical cross-linking agents and anti- neoglycopolymers may not only serve as effective non-
bodies [51, 56, 78]. In support of this mechanism, we covalent inhibitors of rolling but also as agents that elicit
previously found that multivalent carbohydrate displays cleavage of a covalent bond that disrupts L-selectin
designed to mimic the natural L-selectin ligands pro- function. Inhibition of rolling by induction of shedding
mote L-selectin downregulation, but the corresponding provides a new avenue for the generation of anti-inflam-
monovalent ligands do not [57, 64]. These multivalent matory agents.
ligands can cluster L-selectin at the cell surface [65, 74]. There are additional practical reasons for employing
Because the product of neoglycopolymer treatment is a shedding versus rolling assay. Monitoring L-selectin
soluble L-selectin, neoglycopolymer binding appears to downregulation by flow cytometry is convenient as
trigger a protease that produces a cleaved L-selectin smaller quantities of potential inhibitors are required
product. This process may occur through induction of (approximately 10-fold less than those used for a typical
a signal transduction cascade that leads to protease rolling assay), and the assay is not time-consuming.
activation [79] but other mechanisms are possible [77]. Moreover, a prerequisite for the rolling assay is a supply
Agents that induce L-selectin shedding may be espe- of a rolling substrate (e.g., GlyCAM-1 or PNAd), and
cially potent inhibitors of L-selectin function. these materials are not commercially available. Never-
Our results indicate that multivalent ligands that are theless, determining the effectiveness of a compound
highly effective inhibitors of rolling also promote as an inhibitor of cell rolling is valuable because the
L-selectin shedding. Moreover, multivalent ligands that assay is carried out under physiological shear stresses,
do not induce L-selectin cleavage are significantly less which are the conditions that leukocytes experience in
potent in blocking L-selectin-mediated rolling. The con- the blood vessels. We suggest that the shedding assay
can be used to rapidly identify ligands for further charac-centrations required to inhibit L-selectin-mediated roll-
terization in a cell-rolling assay.ing, however, are lower than those used to elicit
L-selectin downregulation as judged by flow cytometry.
SignificanceFor example, the IC50 value of compound 1 in the rolling
assay with GlyCAM-1 is 1 M but the concentration of
Determining the required structural parameters for in-1 employed in the shedding assay is 270M. Differences
hibitors of L-selectin-mediated rolling provides theof this type can be attributed to variations in the as-
groundwork for developing therapeutics for inflamma-say conditions. Specifically, L-selectin-mediated rolling
tory diseases. Sulfation of the multivalent saccharidein vitro and in vivo occurs only at a critical threshold of
display is critical for inhibition of L-selectin-mediatedshear stress [60]. Shear stress appears to influences the
rolling, and the specific sites of sulfation are crucial.accessibility of L-selectin on the cell surface by inducing
The effective antagonists of the rolling process thatextension of the microvilli. Thus, we expected that the
we examined may block rolling by direct inhibition ofinhibitors would be more potent in an assay that involves
L-selectin interaction, promotion of L-selectin shed-shear stress (i.e., the rolling assay) than in a static assay
ding, or both. The potential utility of eliciting shedding(i.e., the flow cytometry assay). Although there is a rela-
is reflected in the findings that many nonsteroidal anti-tionship between ligand activity in the two assays, the
inflammatory drugs have been found to induce L-selec-exact concentration of ligand required to elicit a specific
tin cleavage [14, 53]. Competitive inhibitors of theresponse cannot be compared directly.
L-selectin ligands are dependent on equilibrium for
cell-surface binding. Conversely, agents that induce
Shedding as an Assay for Screening Inhibitors L-selectin shedding could inhibit rolling for a longer
of L-Selectin-Mediated Rolling duration and therefore may be more effective thera-
Many L-selectin inhibition studies are conducted under peutics. Because our results indicate that mimics of
static conditions as in an enzyme-linked immunosorbent the natural L-selectin ligands displaying multiple cop-
assay (ELISA) [36–38, 41, 47, 73, 80–85]. We previously ies of specific sulfated saccharide epitopes can induce
demonstrated that compounds that bind L-selectin un- L-selectin shedding and inhibit rolling, screening for
der static conditions do not always inhibit L-selectin- compounds that promote L-selectin downregulation
may lead to the discovery of highly effective inhibitorsmediated rolling under conditions of shear stress [46].
of rolling.Moreover we have found that highly effective inhibitors
of L-selectin-mediated rolling (neoglycopolymers sub-
Experimental Proceduresstituted with 3,6-disulfo Lex 1, 6-sulfo sLex 4, and 3,6-
disulfo galactose 5) induce shedding. The ligands inca- Reagents, Antibodies, and Cells
pable of blocking rolling (neoglycopolymers displaying All chemicals used were purchased from Sigma (St. Louis, MO)
unless otherwise noted. Mouse pre-B cell line 300.19 transfectedepitopes 3,6-disulfo Lex 2 and sLex 3) were unable to
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with human L-selectin was a generous gift of Dr. G.S. Kansas (North- soluble L-selectin and purchased L-selectin protein were probed
with nonspecific sheep anti-human IgG antibody. Both control West-western University, Chicago, IL). GlyCAM-1 was a generous gift from
Dr. S.D. Rosen (University of California, San Francisco). Fluorescein ern blots were incubated with sheep anti-human IgG antibody chem-
ically conjugated to peroxidase and the bands visualized by ECLisothiocyanate (FITC)-conjugated antibodies were purchased from
BD Pharmingen (San Diego, CA). Ficoll-Paque PLUS was obtained reagents and exposure to X-ray film.
from Amersham Pharmacia Biotech (Piscataway, NJ). HBSS (Hanks’
balanced salt solution) without Ca2 or Mg2 and Dulbecco’s phos- Rolling Inhibition by Neoglycopolymers
phate buffered saline (dPBS), RPMI-1640 media, fetal bovine serum Rolling assays were performed as described previously [46]. Briefly,
(FBS), penicillin, and streptomycin were purchased from Invitrogen mouse pre-B cells (300.19) transfected with human L-selectin were
(Rockville, MD). Bovine serum albumin (BSA) was obtained from pre-incubated with the compound to be assessed for 5 min in HBSS
Research Organics (Cleveland, OH). Polyclonal sheep anti-human containing 2 mg/mL bovine serum albumin, 2 mM CaCl2, and 10 mM
L-selectin antibody and L-selectin protein were purchased from HEPES (pH 7.4). Cells were perfused at room temperature through a
R&D Systems (Minneapolis, MN). Peroxidase-conjugated donkey laminar flow chamber coated with an L-selectin ligand, either Gly-
anti-sheep IgG was obtained from Research Diagnostics, Inc (Flan- CAM-1 or PNAd. IC50 values were determined by the concentration
ders, NJ). Sheep anti-human IgG was obtained from Polysciences, of saccharide required to inhibit 50% of cell rolling in relation to
Inc (Warrington, PA). Microcon centrifugal concentrators were ob- controls.
tained from Millipore Corp. (Bedford, MA). Enhanced chemilumines-
cence (ECL) reagents were purchased from Amersham Biosciences
Acknowledgments(Buckinghamshire, England). Jurkat T-lymphoma cells were grown
in RPMI-1640, 10% FBS, and 100 U of the antibiotics penicillin and
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